Targacept, Inc. to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the 15th Annual BIO CEO & Investor Conference at The Waldorf Astoria New York in New York City on Monday, February 11, 2013 at 1:00 p.m. Eastern Time.